Trillium Asset Management’s Novartis NVS Stock Holding History

Trillium Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,852	Closed	-$219K	–	240
2018 Q4	$219K	Sell	2,852 -627	-18%	-$48.8K	0.01%	225
2018 Q3	$269K	Sell	3,479 -263	-7%	-$19.4K	0.01%	224
2018 Q2	$253K	Sell	3,742 -59,791	-94%	-$4.13M	0.01%	221
2018 Q1	$4.6M	Sell	63,533 -59,323	-48%	-$4.52M	0.25%	113
2017 Q4	$9.24M	Sell	122,856 -1,776	-1%	-$134K	0.51%	81
2017 Q3	$9.59M	Buy	124,632 +7,684	+7%	+$580K	0.55%	73
2017 Q2	$8.75M	Buy	116,948 +7,677	+7%	+$544K	0.52%	77
2017 Q1	$7.27M	Buy	109,271 +34,949	+47%	+$2.33M	0.46%	85
2016 Q4	$4.85M	Buy	74,322 +13,597	+22%	+$882K	0.32%	103
2016 Q3	$4.3M	Sell	60,725 -1,383	-2%	-$101K	0.28%	114
2016 Q2	$4.59M	Sell	62,108 -3,813	-6%	-$263K	0.3%	111
2016 Q1	$4.28M	Sell	65,921 -102,762	-61%	-$6.99M	0.29%	118
2015 Q4	$13M	Sell	168,683 -50,860	-23%	-$4.04M	0.88%	42
2015 Q3	$18.1M	Buy	219,543 +7,555	+4%	+$672K	1.27%	14
2015 Q2	$18.7M	Buy	211,988 +2,173	+1%	+$199K	1.2%	19
2015 Q1	$18.5M	Buy	209,815 +2,870	+1%	+$255K	1.2%	21
2014 Q4	$17.2M	Buy	206,945 +9,236	+5%	+$766K	1.17%	22
2014 Q3	$16.7M	Buy	197,709 +72,256	+58%	+$5.85M	1.44%	11
2014 Q2	$10.2M	Buy	125,453 +11,147	+10%	+$877K	0.87%	42
2014 Q1	$8.71M	Buy	114,306 +4,253	+4%	+$310K	0.82%	51
2013 Q4	$7.93M	Buy	110,053 +10,399	+10%	+$723K	0.78%	56
2013 Q3	$6.85M	Sell	99,654 -26,912	-21%	-$1.78M	0.76%	53
2013 Q2	$8.02M	Buy	+126,566	New	+$8.23M	0.99%	40

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Trillium Asset Management's NVS Position: Q1 2019 in Review

Trillium Asset Management sold out of Novartis (NVS) in Q1 2019, closing a stake of 2,852 shares — an estimated $219K sold.

Trillium Asset Management first reported a position in NVS in Q2 2013 and held it in 23 quarters. The position peaked at $18.7M in Q2 2015. 1,134 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

Trillium Asset Management reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
Trillium Asset Management sold 2,852 Novartis shares in Q1 2019, an estimated $219K.
Trillium Asset Management first reported a position in Novartis in Q2 2013 and held it in 23 quarters.
Trillium Asset Management's Novartis position peaked at $18.7M in Q2 2015.
1,134 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Trillium Asset Management's 13F filing for Q1 2019, filed 6 May 2019.